Aurora Fire Rescue fights back against cancer risks with new screenings, turnout gear
Firefighters have some of the highest risks for job-related cancer. According to the CDC, they are 9% more likely to be diagnosed with cancer than the average American because of the chemicals that can be released in fires and the chemicals used to protect them from those fires.
"The problem with this inner shell is it contains PFAS, and PFAS contributes to firefighter cancer," said Aurora Fire Rescue Assistant Chief Hunter Hackbarth. PFAS stands for per- and polyfluoroalkyl substances, but they're also known as "forever chemicals." They don't break down into the environment readily and include dozens of substances known to cause a variety of health problems.
According to the International Association of Fire Fighters, 72% of their members' line-of-duty deaths in 2023 were due to occupational cancer.
"We have had two retirees that have passed from cancer. We have other retirees that are managing some cancer issues right now," said Hackbarth.
That's why Aurora Fire Rescue is investing in programs to keep its men and women safe. First, they are starting lifespan cancer screenings for their firefighters through a federal government grant, and they are getting new gear free from cancer-causing PFAS.
"Which is a single-layer gear, protective outer shell that we wear for medical calls, car accidents, auto extrication, wildland fire and general use compared to our structure, firefighting gear," said Hackbarth.
The idea is that since the majority of calls they respond to are not structure fires, they can wear the light gear that doesn't expose them to PFAS like their bunker gear does. They will still have to use and carry their bunker gear, but will use it less often. It's an idea that is a big hit around the firehouse.
"They're a lot lighter. They're a lot easier to walk around and breathe," said firefighter Patrick Slama.
"In the summer, it will be nice," said firefighter Seidel.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Oscar Health (OSCR) Q2 Earnings: What To Expect
Health insurance company Oscar Health (NYSE:OSCR) will be reporting earnings this Wednesday morning. Here's what to expect. Oscar Health beat analysts' revenue expectations by 6.9% last quarter, reporting revenues of $3.05 billion, up 42.1% year on year. It was a stunning quarter for the company, with a solid beat of analysts' EPS estimates. Is Oscar Health a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Oscar Health's revenue to grow 33.7% year on year to $2.97 billion, slowing from the 46% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.84 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Oscar Health has missed Wall Street's revenue estimates four times over the last two years. Looking at Oscar Health's peers in the health insurance providers segment, some have already reported their Q2 results, giving us a hint as to what we can expect. CVS Health delivered year-on-year revenue growth of 8.4%, beating analysts' expectations by 5.1%, and Alignment Healthcare reported revenues up 49%, topping estimates by 5.7%. CVS Health's stock price was unchanged after the resultswhile Alignment Healthcare was up 5.7%. Read our full analysis of CVS Health's results here and Alignment Healthcare's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the health insurance providers stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.3% on average over the last month. Oscar Health is down 17% during the same time and is heading into earnings with an average analyst price target of $11.29 (compared to the current share price of $13.95). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Tennessee readies for execution of man with working implanted defibrillator
NASHVILLE, Tenn. (AP) — Tennessee is gearing up for an execution on Tuesday that experts say would likely mark the first time a man has been put to death with a working defibrillator in his chest. Gov. Bill Lee declined Monday to grant a reprieve, clearing the way for Byron Black's execution after a legal battle and ongoing uncertainty about whether the implantable cardioverter-defibrillator will shock his heart when the lethal drug takes effect. The nonprofit Death Penalty Information Center said it's unaware of any other cases in which a person on death row made similar claims to Black's about defibrillators or pacemakers. Black's attorneys said they haven't found a comparable case, either. Lee said the courts have "universally determined that it is lawful to carry out the jury's sentence of execution given to Mr. Black for the heinous murders of Angela Clay and her daughters Lakeisha, age 6, and Latoya, age 9." The U.S. Supreme Court on Monday rejected Black's appeals. The execution would be Tennessee's second since May, after a pause for five years, first because of COVID-19 and then because of missteps by state corrections officials. Twenty-seven men have died by court-ordered execution so far this year in the U.S., and nine other people are scheduled to be put to death in seven states during the remainder of 2025. The number of executions this year exceeds the 25 carried out last year and in 2018. It is the highest total since 2015, when 28 people were put to death. Black's condition Black, 69, is in a wheelchair, and he has dementia, brain damage, kidney failure, congestive heart failure and other conditions, his attorneys have said. The implantable cardioverter-defibrillator he has is a small, battery-powered electronic device that is surgically implanted in the chest. It serves as a pacemaker and an emergency defibrillator. Black's attorneys say in order to be sure it's off, a doctor must place a programming device over the implant site, sending it a deactivation command, with no surgery required. In mid-July, a trial court judge agreed with Black's attorneys that officials must have his device deactivated to avert the risk that it could cause unnecessary pain and prolong the execution. But the state Supreme Court intervened July 31 to overturn that decision, saying the other judge lacked the authority to order the change. The state has disputed that the lethal injection would cause Black's defibrillator to shock him. Even if shocks were triggered, Black wouldn't feel them, the state said. Black's attorneys have countered that even if the lethal drug being used, pentobarbital, renders someone unresponsive, they aren't necessarily unaware or unable to feel pain. Kelley Henry, Black's attorney, said the execution could become a 'grotesque spectacle.' The legal case also spurred a reminder that most medical professionals consider participation in executions a violation of health care ethics. Black's case Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting Clay's estranged husband. Linette Bell, whose sister and two nieces were killed, recently told WKRN-TV: 'He didn't have mercy on them, so why should we have mercy on him?' Intellectual disability claim In recent years, Black's legal team has unsuccessfully tried to get a new hearing over whether he is intellectually disabled and ineligible for the death penalty under U.S. Supreme Court precedent. His attorneys have said that if they had delayed a prior attempt to seek his intellectual disability claim, he would have been spared under a 2021 state law. Nashville District Attorney Glenn Funk contended in 2022 that Black is intellectually disabled and deserved a hearing under that 2021 law, but the judge denied it. That is because the 2021 law denies a hearing to people on death row who have already filed a similar request and a court has ruled on it 'on the merits." In Funk's attempt, he focused on input from an expert for the state in 2004 who determined back then that Black didn't meet the criteria for what was then called "mental retardation.' But she concluded that Black met the new law's criteria for a diagnosis of intellectual disability. Black also sought a determination by the courts that he is incompetent to be executed.
Yahoo
an hour ago
- Yahoo
Guardians reliever Nic Enright, battling lymphoma, earns emotional first save
NEW YORK (AP) — The first career save for Nic Enright was a particularly meaningful one. Enright, who was diagnosed with Hodgkin lymphoma in late 2022 and is scheduled to complete his treatments later this year, allowed an unearned run in the 10th inning Monday night to close out the Cleveland Guardians' 7-6 win over the New York Mets. 'He was almost crying on the field just now,' Guardians manager Stephen Vogt said. 'If you read his story, it's pretty inspirational.' Cleveland selected Enright in the 20th round of the 2019 amateur draft out of Virginia Tech. He received his diagnosis Dec. 22, 2022 — 15 days after the Miami Marlins took him in the Rule 5 draft. After four rounds of immunotherapy in early 2023, Enright made nine minor league rehab appearances for the Marlins before being designated for assignment and returning to the Guardians in late May. He missed most of last season due to a right shoulder strain, but went 2-1 with a 1.06 ERA in 16 appearances with Triple-A Columbus. The right-hander has one more round of cancer treatment scheduled for November. 'I made the decision when I was diagnosed in 2022 with Hodgkin lymphoma that I wasn't going to let that define my life and dictate how I was going to go about my life,' Enright said. 'It's something where, for anyone else who is going through anything similar, (it shows) I haven't just holed up in my house and felt sorry for myself this whole time.' Enright made his major league debut May 25 and has a 2.01 ERA in 19 appearances for the Guardians, whose bullpen is in flux with All-Star closer Emmanuel Clase on paid leave as part of a sports gambling investigation. Hunter Gaddis and Cade Smith pitched the eighth and ninth innings Monday before Enright entered with a two-run lead. He gave up a two-out RBI single to Brett Baty before retiring Luis Torrens on a fly out to the warning track in right. 'I definitely held my breath as I saw Nolan (Jones) kind of keep running,' Enright said. 'But I had faith. As he kind of got closer to the wall, I realized it was losing steam.' Enright was showered with beer by teammates in the locker room. 'I was so happy, oh, I was going nuts in here,' Guardians starting pitcher Slade Cecconi said with a smile. 'I was going absolutely berserk. He came in running up the stairs, smile on his face.' Enright thanked his wife, his parents and the rest of his family for their support throughout an interview at his locker. He got the ball from the final out and plans to set aside his uniform and hat as well as a lineup card. 'Really, really cool,' Enright said. 'These last couple of years, especially, I've gone through a lot of adversity and just everything that's gone on. And so for me, it's being able to reflect on those in these moments. I think that helps being able to slow the game down. Because it hasn't exactly been a red-carpet rollout for my career trajectory.' ___ AP MLB:
